IL-17A RNA aptamer: possible therapeutic potential in some cells, more than we bargained for in others?
Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, UK.
Rosella
R
Doble
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
Michael F
MF
McDermott
Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, UK.
Özlem
Ö
Cesur
Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds, Leeds, UK.
Nicola J
NJ
Stonehouse
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; Centre for Skin Sciences, School of Life Sciences, University of Bradford, Bradford, UK; Department of Dermatology, St Luke's Hospital, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK; Chapel Allerton Hospital, Leeds Musculoskeletal Biomedical Research Unit, National Institute for Health Research, Leeds, UK. Electronic address: M.Wittmann@leeds.ac.uk.
Miriam
M
Wittmann
D052157:Aptamers, Nucleotide / Q000235:genetics / Q000627:therapeutic use*; D018920:Coculture Techniques; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D020381:Interleukin-17 / Q000235:genetics*; D015603:Keratinocytes / Q000166:cytology / Q000502:physiology*; D011565:Psoriasis / Q000235:genetics / Q000628:therapy*; D013601:T-Lymphocytes / Q000166:cytology / Q000502:physiology*
D052157:Aptamers, Nucleotide; C508717:IL17A protein, human; D020381:Interleukin-17